The first MOU, signed with Roche, outlines a joint effort to explore advanced AI and digital technologies aimed at accelerating clinical trial recruitment, improving market access, and strengthening business intelligence.
Enigma Health — a spinoff from the SingHealth Duke-NUS Academic Medical Centre — has signed two Memoranda of Understanding (MOUs) at ATxSummit 2025 to expand its flagship product's reach and capabilities.
Developed by a team of clinicians and AI scientists, Enigma is a healthcare agentic artificial intelligence (AI) platform designed for healthcare. It focuses on workflow optimisation by streamlining data-intensive and time-consuming processes while maintaining strong data security and regulatory compliance.
